Jon Markman

Jon Markman

Jon Markman is the editor of Trader’s Advantage, a daily trading service that leverages his unique swing trading principles and aims to capture profits of 7% to 15% — and often much more with his options trades — in less than 90 days. By combining technical analysis with underlying fundamentals, Jon recommends beaten down stocks on the brink of reversal and powerful momentum stocks breaking out to new highs.

In CounterPoint Options Jon helps options traders lock in consistent profits from the volatility that rocks the market. At its heart is a proprietary trading system, Magnitude, that pinpoints indexes or sectors that have reached a critical inflection point — then translates that signal into profitable trades.

CounterPoint Options keeps volatility options trading very simple, focusing on the most popular, highly traded exchange-traded funds (ETFs) that are headed for a key reversal. Magnitude scans the market and allows subscribers to take advantage of these very liquid trading opportunities.

When CounterPoint Options first launched, it was focused solely on trading the VIX, commonly known as the “fear index.” When traders start buying up put options as “portfolio insurance,” the VIX spikes — a phenomenon that we’ll either trade directly, or use to inform our ETF trades on specific slices of the market. Our agile (and highly lucrative) strategy lets us turn volatility into profits… just like professional traders and hedge funds have been doing for years.

CounterPoint Options helps individual traders make steady, consistent profits from a very methodical approach to growing your portfolio in the midst of a turbulent market.

A pioneer in the development of stock-rating systems and screening software, Jon Markman is co-inventor on two Microsoft patents and author of the best-selling books Swing Trading and Online Investing. He was portfolio manager and senior investment strategist at a multi-strategy hedge fund from 2002 to 2005; managing editor and columnist at CNBC on MSN Money from 1997 to 2002; and an editor, investment columnist and investigative reporter at the Los Angeles Times from 1984 to 1997.

Jon won a Gerald Loeb Award for Distinguished Financial Journalism for his columns explaining market chicanery in 2002; Society of Professional Journalists awards for his 2001 reporting on Enron and the post-Sept. 11-investment environment; and was a news editor on the Los Angeles Times staff that won Pulitzer Prizes for spot-news reporting in 1992 and 1994.

A graduate of Duke University and the Columbia University Graduate School of Journalism, Jon speaks frequently on investment topics at conferences nationwide, as well as on TV and radio.

Recent Articles

A Wal-Mart Special on WMT Calls

Technicals, WMT seasonality signal that it's time to pick up Wal-Mart calls at a bargain for a cheap way to profit from this retailer's rise.

Is It Finally Time to Friend Facebook?

Facebook is still surrounded by skepticism, but it shows several similarities to another stock no one believed in -- and one that sure prove its skeptics wrong.

The Stock That’s Lighting Up Amazon’s New Kindle Fire

Part of the new Kindle Fire HD’s allure is AT&T’s wireless service bundled in. Buy this call option to catch this spark in your portfolio.

Hershey Starting to Sugar-Coat the World

Steady dividend payer Hershey (HSY) has had a solid 2012, and its growth in international markets offers more promise for the future.

Bet on Biotech With ViroPharma

Biotech stocks are speculative picks. But if you're willing to take a risk, ViroPharma is the way to go.